Diligence memo · auto-generated · as of July 2, 2026

Jinzanghuang Tibet Pharmaceuticals, Inc.

Jinzanghuang Tibet Pharmaceuticals, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Jinzanghuang Tibet Pharmaceuticals, Inc. operates in Business Services, based in SHANDONG PROVINCE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Jinzanghuang Tibet Pharmaceuticals, Inc. has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $1.0M on 2012-07-31.

Most recent recorded round closed around 2012-07-31.

Valuation (modeled)modeled

Provath models Jinzanghuang Tibet Pharmaceuticals, Inc. at approximately $32M (range $680K–$358M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.78× the median modeled value of Pre-Seed Business Services companies in 2010–2012 (152 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 13.9 yr ago; this sector typically re-raises about every 12 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 55% of Business Services peers (2439 compared).

Modeled value ranks above 73% of those peers.

Closest niche peers: Local Offer Network, Inc., Empathica Inc, CLS Holdings Corp, BusyContractor.com, Inc, Green Bull Products Inc..

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.